Recombinant Human MMP13 Protein，His

MMP13, also known as collagenase-3, is a member of the matrix metalloproteinase (MMP) family, which plays a critical role in the degradation of extracellular matrix components, particularly collagen. Its activity is particularly relevant in physiological processes such as tissue remodeling during development and wound healing, as well as in pathological conditions, including arthritis, cancer metastasis, and cardiovascular diseases. MMP13 is predominantly expressed in cartilage and is implicated in the pathological degradation of cartilage in osteoarthritis. The regulation of MMP13 activity is complex and involves various factors, including tissue inhibitors of metalloproteinases (TIMPs) and signaling pathways influenced by inflammatory cytokines. Due to its significant role in disease progression, MMP13 has emerged as a potential therapeutic target, making the study of its recombinant protein particularly important. The generation of recombinant MMP13 allows for detailed investigation of its biochemical properties, substrate specificity, and regulatory mechanisms, as well as the development of specific inhibitors that can potentially mitigate its overactivity in various disease states. Understanding the structure-function relationship of MMP13 and its role in disease pathways is crucial for the design of novel therapeutic strategies aimed at controlling its activity and mitigating the associated tissue damage. This line of research has important implications not only for understanding the mechanisms underlying degenerative diseases but also for the development of innovative treatments that can improve patient outcomes.